SCHEMBL6602556

SCHEMBL6602556

CCCN(CCC)CCOc1cc(NC(=O)c2cncc(-n3cccc3)c2)ccc1OC

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 2/20 0.51
CHRNA3 P32297 2/20 0.51
MCHR1 Q99705 11/20 0.50
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
HTR2C P28335 1/20 0.43
MAPT P10636 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SIRT3 Q9NTG7 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603020 0.88 MCHR1 (0.58) CHRNB4CHRNA3MCHR1HTR2C
SCHEMBL6603098 0.85 MCHR1 (0.52) CHRNB4CHRNA3MCHR1PDE4APDE4B
SCHEMBL6606159 0.83 ALDH1A1 (0.56) MCHR1MAPTRAB9ASMN1; SMN2
SCHEMBL7723668 0.79 MCHR1 (0.61) MCHR1MAPTRAB9ASMN1; SMN2
SCHEMBL6602569 0.78 MCHR1 (0.65) MCHR1HTR2CMAPT
SCHEMBL6604498 0.78 MCHR1 (0.55) MCHR1PDE4APDE4BPDE4CPDE4D
SCHEMBL6605156 0.78 MCHR1 (0.65) MCHR1HTR2CMAPT
SCHEMBL6898088 0.78 MCHR1 (0.67) MCHR1HTR2CRAB9ASMN1; SMN2
SCHEMBL6896989 0.78 MCHR1 (0.67) MCHR1HTR2CRAB9ASMN1; SMN2
SCHEMBL6921907 0.78 MCHR1 (0.80) MCHR1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102535-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-09-29 EP claimed
EP-1102535-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2001-05-30 EP claimed
WO-2000006085-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO claimed
EP-1102535-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-09-29 EP disclosed
EP-1102535-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2001-05-30 EP disclosed
WO-2000006085-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO disclosed